HomeProductsBioactive CompoundsGPCR & G Protein TargetsAdenosine ReceptorEtrumadenant
Chemical structure of CAS 2239273-34-6

Etrumadenant

CAS No.2239273-34-6
MDL No.MFCD32263040
MFC23H22N8O
MW426.50
InChI KeyBUXIAWLTBSXYSW-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2239273-34-6
Product NameEtrumadenant

Biological Targets

ADORA2A·ADORA2B

Associated Conditions

neoplasm·rectum cancer·non-small cell lung carcinoma·prostate adenocarcinoma·prostate cancer·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers.

Investigational new drugs • Vol. 37, Issue 4 • 2019
PMID: 30569245DOI: 10.1007/s10637-018-0706-6

Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation.

PloS one • Vol. 7, Issue 2 • 2012
PMID: 22389701PMC: PMC3289657DOI: 10.1371/journal.pone.0032416

Adenosine receptors in regulation of dendritic cell differentiation and function.

Blood • Vol. 112, Issue 5 • 2008
PMID: 18559975PMC: PMC2518889DOI: 10.1182/blood-2008-02-136325

Documentation